Bachem Holding AG
BANB
주식 순위
#2534
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
주가
$100.30
시가총액
$7.52B
변동 (1일)
-1.78%
변동 (1년)
49.08%
국가
CH
거래 Bachem Holding AG (BANB)
카테고리
Healthcare
Bachem Holding AG (BANB)의 주가 이력
최고 종가: $105.12 (2026-10-01 기준)
최저 종가: $13.47 (2001-03-01 기준)
최저 종가: $13.47 (2001-03-01 기준)
Bachem Holding AG의 주가 이력 (2001 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | 26.87% |
| 2025 | -3.05% |
| 2024 | -5.47% |
| 2023 | -16.69% |
| 2022 | -35.59% |
| 2021 | 68.81% |
| 2020 | 169.92% |
| 2019 | 28.96% |
| 2018 | -16.46% |
| 2017 | 68.14% |
| 2016 | 64.94% |
| 2015 | 3.94% |
| 2014 | -8.15% |
| 2013 | 45.10% |
| 2012 | -0.04% |
| 2011 | -34.01% |
| 2010 | -12.09% |
| 2009 | -5.58% |
| 2008 | -20.36% |
| 2007 | 13.73% |
| 2006 | 32.09% |
| 2005 | 1.28% |
| 2004 | 12.61% |
| 2003 | 11.00% |
| 2002 | -19.59% |
| 2001 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $534.12 | 25.25% |
US
|
|
| $231.12 | 760.78% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $880.75 | 8.18% |
NL
|
|
| $289.51 | 1.72% |
BE
|
